Kenvue Inc. has seen notable activity amongst institutional investors in recent times.
State Street Corp and
Wahed Invest LLC have both increased their positions, while
Rockefeller Capital Management L.P. and others have reduced their stakes. The company's earnings have been mixed, with Q3 2024 results surpassing estimates even though they have demonstrated disappointment. In the midst of this, participation in esteemed conferences like the
Morgan Stanley Global Consumer & Retail Conference and the
Barclays Global Consumer Staples Conference is ongoing. Interestingly, activism is emerging with
Starboard, a known activist investor, taking a stake in the company and calling for changes. The firm's skin health segment is reportedly hitting financial performance. Kenvue's stock has experienced fluctuations, including reaching a new 1-year high. It is also perceived as a reliable dividend aristocrat. On the innovation front, Kenvue is driving a
Climate Action Strategy and has introduced patented micro-peptide technology with the launch of
Neutrogena® Collagen Bank™. Overall, the market sentiment towards Kenvue appears cautiously optimistic.
Kenvue KVUE News Analytics from Thu, 25 Jul 2024 07:00:00 GMT to Fri, 06 Dec 2024 14:52:51 GMT -
Rating 5
- Innovation 7
- Information 4
- Rumor -2
